Disclosures for "VHB937, a TREM2 Stabilizing and Activating Antibody Strongly Reduces Pathology After Peripheral Administration in a Broad Range of Animal Models for Neuroinflammation and Neurodegeneration"
-
Prof. Stangel has received personal compensation for serving as an employee of Novartis. Prof. Stangel has stock in Novartis. Prof. Stangel has received publishing royalties from a publication relating to health care.
-
Dr. Feuerbach has received personal compensation for serving as an employee of Novartis . Dr. Feuerbach has stock in Novartis. Dr. Feuerbach has received intellectual property interests from a discovery or technology relating to health care.
-
Derya Shimshek has received personal compensation for serving as an employee of Novartis Pharma AG. Derya Shimshek has stock in Novartis Pharma AG. Derya Shimshek has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Gasparini has received personal compensation for serving as an employee of Novartis. Dr. Gasparini has stock in Novartis.
-
Dr. Galimberti has received personal compensation for serving as an employee of Novartis. Dr. Galimberti has stock in Novartis.
-
Mrs. George has received personal compensation for serving as an employee of Novartis Pharma AG. Mrs. George has stock in Novartis Pharma AG. Mrs. George has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Peraus has received personal compensation for serving as an employee of Novartis. Dr. Peraus has stock in Novartis. An immediate family member of Dr. Peraus has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Sovago has received personal compensation for serving as an employee of Novartis Pharma AG. Dr. Sovago has stock in Novartis Pharma AG.